Department of Oncology,
School of Medicine,
State Key Laboratory of Bioelectronics,
School of Biological Science and Medical Engineering,
Department of Oncology, School of Medicine,
State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering
Cailian Wang has not added Biography.
If you are Cailian Wang and would like to personalize this page please email our Author Liaison for assistance.
A strategy for ZnO nanorod mediated multi-mode cancer treatment.
Biomaterials Mar, 2011 | Pubmed ID: 21145104
Study of the enhanced anticancer efficacy of gambogic acid on Capan-1 pancreatic cancer cells when mediated via magnetic Fe3O4 nanoparticles.
International journal of nanomedicine , 2011 | Pubmed ID: 21931488
Daunorubicin-TiO2 nanocomposites as a "smart" pH-responsive drug delivery system.
International journal of nanomedicine , 2012 | Pubmed ID: 22275838
Gambogic acid-loaded magnetic Fe(3)O(4) nanoparticles inhibit Panc-1 pancreatic cancer cell proliferation and migration by inactivating transcription factor ETS1.
International journal of nanomedicine , 2012 | Pubmed ID: 22393285
The real-time neurotoxicity analysis of Fe3O4 nanoparticles combined with daunorubicin for rat brain in vivo.
Journal of biomedical nanotechnology Jun, 2012 | Pubmed ID: 22764410
Silver nanoparticles: a novel radiation sensitizer for glioma?
Nanoscale Dec, 2013 | Pubmed ID: 24126539
Transcriptional silencing of ETS-1 abrogates epithelial-mesenchymal transition resulting in reduced motility of pancreatic cancer cells.
Oncology reports Feb, 2015 | Pubmed ID: 25421630
Is the autophagy a friend or foe in the silver nanoparticles associated radiotherapy for glioma?
Biomaterials Sep, 2015 | Pubmed ID: 26022979
Rituximab-conjugated and doxorubicin-loaded microbubbles combined with ultrasound irradiation inhibits proliferation and induces apoptosis in Raji cell lines.
Oncology reports Feb, 2016 | Pubmed ID: 26718487
Trends and advances in tumor immunology and lung cancer immunotherapy.
Journal of experimental & clinical cancer research : CR Sep, 2016 | Pubmed ID: 27686848
ETS-1: A potential target of glycolysis for metabolic therapy by regulating glucose metabolism in pancreatic cancer.
International journal of oncology Jan, 2017 | Pubmed ID: 27878249
Rituximab-conjugated, doxorubicin-loaded microbubbles as a theranostic modality in B-cell lymphoma.
Oncotarget Jan, 2017 | Pubmed ID: 27902473
A microemulsion co-loaded with Schizandrin A-docetaxel enhances esophageal carcinoma treatment through overcoming multidrug resistance.
Drug delivery Nov, 2017 | Pubmed ID: 28155336
Intracellular pH-responsive and rituximab-conjugated mesoporous silica nanoparticles for targeted drug delivery to lymphoma B cells.
Journal of experimental & clinical cancer research : CR Feb, 2017 | Pubmed ID: 28166836
LincRNAFEZF1-AS1 represses p21 expression to promote gastric cancer proliferation through LSD1-Mediated H3K4me2 demethylation.
Molecular cancer Feb, 2017 | Pubmed ID: 28209170
Targeted microbubbles with ultrasound irradiation and PD-1 inhibitor to increase antitumor activity in B-cell lymphoma.
Nanomedicine (London, England) Feb, 2018 | Pubmed ID: 29338562
Immunomodulatory effects of chemotherapy on blood lymphocytes and survival of patients with advanced non-small cell lung cancer.
International journal of immunopathology and pharmacology , 2019 | Pubmed ID: 30968711
Inertial microfluidic cube for automatic and fast extraction of white blood cells from whole blood.
Lab on a chip Jan, 2020 | Pubmed ID: 31833515
Recurrent Metastatic Penile Cancer Patient with Positive PD-L1 Expression Obtained Significant Benefit from Immunotherapy: A Case Report and Literature Review.
OncoTargets and therapy , 2020 | Pubmed ID: 32368090
A polymer-film inertial microfluidic sorter fabricated by jigsaw puzzle method for precise size-based cell separation.
Analytica chimica acta Jan, 2021 | Pubmed ID: 33384126
Low-cost polymer-film spiral inertial microfluidic device for label-free separation of malignant tumor cells.
Electrophoresis Feb, 2022 | Pubmed ID: 34611912
Development and Validation of an E2F-Related Gene Signature to Predict Prognosis of Patients With Lung Squamous Cell Carcinoma.
Frontiers in oncology , 2021 | Pubmed ID: 34745990
Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial.
Cancer cell 03, 2022 | Pubmed ID: 35245446
High-throughput and label-free enrichment of malignant tumor cells and clusters from pleural and peritoneal effusions using inertial microfluidics.
Lab on a chip May, 2022 | Pubmed ID: 35441644
Identification of six novel prognostic gene signatures as potential biomarkers in Small Cell Lung Cancer.
Combinatorial chemistry & high throughput screening Apr, 2022 | Pubmed ID: 35490316
High Expression of Is Associated with the Poor Prognosis and Immune Infiltration in Lung Adenocarcinoma Patients.
Disease markers , 2022 | Pubmed ID: 35855850
Development and Validation of a DNA Methylation-related Classifier of Circulating Tumour Cells to Predict Prognosis and to provide a therapeutic strategy in Lung Adenocarcinoma.
International journal of biological sciences , 2022 | Pubmed ID: 35982906
A Comprehensive Bioinformatic Analysis for Identification of Myeloid-Associated Differentiation Marker as a Potential Negative Prognostic Biomarker in Non-Small-Cell Lung Cancer.
Pathology oncology research : POR , 2022 | Pubmed ID: 36061144
Evaluation of AMG510 Therapy on -Mutant Non-Small Cell Lung Cancer and Colorectal Cancer Cell Using a 3D Invasive Tumor Spheroid System under Normoxia and Hypoxia.
Bioengineering (Basel, Switzerland) Dec, 2022 | Pubmed ID: 36550998
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。